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P2X7 purinoceptors contribute to the death of
Schwann cells transplanted into the spinal cord
J Luo1,2, S Lee1,3,7, D Wu1, J Yeh1,4, H Ellamushi1,4, AP Wheeler5, G Warnes6, Y Zhang1 and X Bo*,1
The potential to use Schwann cells (SCs) in neural repair for patients suffering from neurotrauma and neurodegenerative
diseases is well recognized. However, significant cell death after transplantation hinders the clinical translation of SC-based
therapies. Various factors may contribute to the death of transplanted cells. It is known that prolonged activation of P2X7
purinoceptors (P2X7R) can lead to death of certain types of cells. In this study, we show that rat SCs express P2X7R and
exposure of cultured SCs to high concentrations of ATP (3–5 mM) or a P2X7R agonist, 20(30)-O-(4-benzoylbenzoyl)ATP (BzATP)
induced significant cell death rapidly. High concentrations of ATP and BzATP increased ethidium uptake by SCs, indicating
increased membrane permeability to large molecules, a typical feature of prolonged P2X7R activation. SC death, as well as
ethidium uptake, induced by ATP was blocked by an irreversible P2X7R antagonist oxidized ATP (oxATP) or a reversible
P2X7R antagonist A438079. oxATP also significantly inhibits the increase of intracellular free calcium induced by minimolar
ATP concentrations. Furthermore, ATP did not cause death of SCs isolated from P2X7R-knockout mice. All these results
suggest that P2X7R is responsible for ATP-induced SC death in vitro. When rat SCs were treated with oxATP before
transplantation into uninjured rat spinal cord, 35% more SCs survived than untreated SCs 1 week after transplantation.
Moreover, 58% more SCs isolated from P2X7R-knockout mice survived after being transplanted into rat spinal cord than SCs
from wild-type mice. This further confirms that P2X7R is involved in the death of transplanted SCs. These results indicate that
targeting P2X7R on SCs could be a potential strategy to improve the survival of transplanted cells. As many other types of
cells, including neural stem cells, also express P2X7R, deactivating P2X7R may improve the survival of other types of
transplanted cells.
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Schwann cells (SCs) have been considered as a potential
source for cell-based therapies for neurotrauma and some
neurodegenerative diseases, as this type of peripheral glial
cell can be obtained from the patients and used for autologous
transplantation. SCs can be expanded efficiently in vitro with
improved culture formula to make the cell-based therapy
clinically feasible. The first case of clinical trial of SC
transplantation into injured spinal cord has been carried out
by the Miami Project to Cure Paralysis. SCs transplanted into
the central nervous system (CNS) can promote axon
regeneration and remyelination and improve functional
recovery in animal models of spinal cord injury.1 However,
early and extensive cell death occurring after transplantation
is a common phenomenon and a significant obstacle that
hinders the success of cell-based therapies.2,3 Therefore, a
crucial issue of cell-based therapies is how to improve cell
survival after transplantation. Many factors may contribute to
the death of transplanted cells, such as inflammation, immune
response, oxidative stress and lack of growth factors.
Although various approaches have been investigated to
tackle those factors,4 the survival of transplanted cells is still
far from being satisfactory, indicating that additional unidenti-
fied factors are involved. One such factor could be ATP
released at the transplantation site. Tissue damage and
inflammation lead to the release of various cytokines and
mediators as well as high levels of extracellular ATP.5,6 The
transplantation procedure will inevitably cause a certain
degree of tissue damage and instant ATP release from the
injured cells. Moreover, the space occupied by the trans-
planted cells will press the surrounding host tissues, which
may trigger by mechanical deformation further release of ATP
from astrocytes.7 Inflammation and ischemia can also trigger
ATP release from microglia8 and oligodendrocytes.9 Such
local increases in extracellular ATP level may activate P2X7
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purinoceptors (P2X7R) on the transplanted cells and induce
cell death.
Activation of P2X7R by ATP leads to rapid opening of
cation channels.10–12 Prolonged exposure to high concentra-
tions of ATP (4100mM) makes homomeric P2X7R permeable
to large cations. Pores formed on the membrane allow
molecules up to 900 Da (such as YO-PRO-1 and ethidium)
to pass through the cell membrane and lead to cell death.13
P2X7R-mediated cell death has been reported in several
types of cells, such as macrophages14 and dendritic cells.15
In the nervous system, functional P2X7R is expressed
by microglia, astrocytes,16 oligodendrocytes,17 and some
neurons in the brain and spinal cord.18 Prolonged
stimulation of P2X7R is reported to cause death of
microglia,19 photocells,20 and neural progenitor cells.21
P2X7R has been identified on mouse SCs by electrophysiology
and immunohistochemistry.22 In the current study, we
investigated whether ATP could induce SC death in vitro
and explored the role of P2X7R in ATP-induced SC
death. Furthermore, we examined whether P2X7R in SCs
contributed to SC death after transplantation into the spinal
cord.
Results
SCs express P2X7R. Cultured rat SCs were double-
immunostained for P2X7R and the SC marker S100.
P2X7R immunoreactivity was distributed all over the cells,
whereas S100 immunoreactivity was much stronger in the
nuclei (Figure 1a). PCR using rat SC cDNAs and a pair of
P2X7R-specific primers produced a DNA band of the same
size as that using P2X7R cDNA as template, demonstrating
that the P2X7R mRNA is expressed in SCs (Figure 1b).
Immunostaining of rat sciatic nerves showed the colocaliza-
tion of P2X7R and S100 immunoreactivity in SCs (Figure 1c).
The P2X7R immunoreactivity was stronger in Schmidt-
Lanterman incisures, the tubular cytoplasm structures inside
the myelin sheath. P2X7R immunoreactivity was absent or
very weak on axons labeled with N52 antibody for neurofila-
ment 200 (Figure 1c). A similar pattern of immunostaining of
P2X7R and S100 was seen in the sciatic nerve of wild-type
C57Bl/6J mice (Figure 1d). However, no immunoreactivity for
P2X7R was detected in the sciatic nerve from the P2X7R-
knockout mice from GlaxoSmithKline (Figure 1d). This result
confirms the specificity of the P2X7R antibody.
Figure 1 P2X7R is expressed in isolated SCs and sciatic nerves from rat and mouse. (a) Photomicrograph of cultured rat SCs double-immunostained for the SC marker
S100 and P2X7R. (b) Detection of P2X7R mRNA in cultured rat SCs using PCR. (c) Photomicrographs of longitudinal sections through the rat sciatic nerve double-
immunostained for S100 and P2X7R or NF200 and P2X7R. Scale bar, 50 mm. (d) Photomicrographs of longitudinal sections through the sciatic nerves from C57Bl/6J
wild-type (WT) and P2X7R-knockout (KO) mice double-immunostained for S100 and P2X7R. Scale bar, 100mm
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ATP induces the death of cultured SCs dose-dependently.
During an experiment looking for potential factors that might
induce SC death, we exposed SCs to various concentrations
of ATP. No obvious morphological change occurred to SCs
exposed to ATP concentrations up to 1 mM (Figure 2a);
however, SCs exposed to ATP concentrations higher than
2 mM underwent significant morphological changes within
10–15 min; the higher the concentration, the quicker the
changes occurred. Cell processes started to withdraw and
cells gradually rounded up (Figure 2a). Most of the SCs
detached from the culture dishes after exposure to 5 mM
ATP for 1 h. Cells were then dissociated, labeled with
Annexin V Apoptosis Assay kit and subjected to flow
cytometry to measure cell viability. No significant SC death
occurred after exposure to 1 or 2 mM ATP (Figure 2c).
However, at 3 mM cell death became significant and 4 and
5 mM ATP induced even more profound cell death (Figures
2b and c).
As only high ATP concentrations induced SC death, P2X7R
is implicated to be the receptor responsible for SC death. We
further tested 20(30)-O-(4-benzoylbenzoyl)ATP (BzATP), the
most potent, although not highly specific, agonist for P2X7R.
Cells exposed to 200mM BzATP started to withdraw their
processes within 15 min. By 30 min, nearly all the cells
rounded and many detached. Cell viability assay showed that
significantly lower percentage of cells was alive after exposure
to BzATP than the control group (Figure 2c). These results
indicate that P2X7R may mediate the SC death induced by
ATP and BzATP.
P2X7R antagonists prevent ATP- or BzATP-induced SC
death. To further confirm that P2X7R is responsible
for ATP-induced SC death, we tested whether blocking
P2X7R could prevent ATP-induced SC death. Oxidized
ATP (oxATP), an irreversible and slow action P2X7R
antagonist,23 was applied to the cultured SCs to a
final concentration of 350 mM for 2 h. oxATP-treated
and -untreated cells were then exposed to various
concentrations of ATP or 200 mM BzATP for 1 h. During
this period, cells treated with oxATP did not show
observable morphological changes. SCs were then
processed for cell viability assay. Pretreatment with oxATP
did not cause significant cell death (Figure 2c); however,
oxATP pretreatment completely prevented cell death
induced by various concentrations of ATP and 200 mM
BzATP (Figure 2c).
Figure 2 ATP induces SC death dose-dependently in vitro. (a) Phase contrast images showing SCs in culture with or without exposure to ATP for 30 min. (b) Flow
cytometry cell viability assay showing the proportions of live cells after exposure to 3, 4, 5 mM ATP for 1 h. (c) The percentage of live SCs after being exposed to increasing
concentrations of ATP or BzATP (200mM) with or without oxATP (350mM) or A438079 (100mM).þPo0.05, þþPo0.01, þþþPo0.001 (compared with the group without
ATP); *Po0.05, **Po0.01, ***Po0.001 (compared between the corresponding groups with or without one of the antagonists), single factor AVNOA, n¼ 3–7
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oxATP was reported to attenuate pro-inflammatory signaling
by acting through P2 receptor-independent mechanisms.24
Therefore, there exists certain possibility that the prevention
of ATP-induced cell death by oxATP may not be solely
through the blockade of P2X7R. We then tested a reversible
specific P2X7R antagonist, A438079.25 At 100mM, A438079
itself did not affect the morphology and viability of SCs,
but it also completely blocked the ATP- and BzATP-induced
cell death (Figure 2c). The results demonstrate that both
oxATP and A438079 can protect SCs from ATP-induced
cell death, indicating that P2X7R is responsible for
SC death.
ATP does not induce death of SCs from P2X7R-knockout
mice. Experiment on SCs from P2X7R-knockout mice
further supports that P2X7R is responsible for ATP-induced
SC death. After exposure to 5 mM ATP for 1 h, no
morphological change and significant cell death were
detected in SCs dissociated from P2X7R-knockout mice
(C57Bl/6J), whereas most of the SCs from the wild-type mice
of the same strain were dead (Figure 7a). Compared with rat
SCs, ATP-induced death is more profound in SCs from the
wild-type mice.
P2X7R antagonists block ATP- and BzATP-induced
ethidium uptake into SCs. Cell death induced by high
concentrations of ATP is attributed to the prolonged
activation of P2X7R, which leads to pore formation on cell
membranes.12,13 To test whether ATP can also induce pore
formation in SCs, SCs were exposed to various concentra-
tions of ATP in the presence of 10 mM ethidium bromide.
Using time-lapse confocal microscopy, it was shown that a
gradual increase in ethidium uptake into SCs occurred at
ATP concentrations above 1 mM (Figure 3c). Under an
epifluorescence microscope, we also observed that ethidium
uptake occurred at ATP concentrations above 1 mM (Figures
3a and b). By comparing the corresponding bright-field and
fluorescence images of the same microscopic field taken at
20 min after exposure to ATP, it is evident that the extent of
ethidium uptake is correlated with the morphological changes
of SCs (Figure 3a). Quantification of ethidium fluorescence
intensities in SCs 20 min after the exposure to ATP shows
that ethidium uptake is concentration-dependent (Figure 3b).
After pretreatment of SCs with 350mM oxATP for 2 h
or 100mM A438079 for 20 min, ATP at all tested concentra-
tions did not induce ethidium uptake (Figure 3b),
indicating the blockade of P2X7R prevents the pore forma-
tion on SCs.
We also noticed that high concentrations of ATP did not
induce morphological change and ethidium uptake in a few
contaminated fibroblasts (indicated by green arrows in
Figure 3a), indicating that those fibroblasts are resistant to
ATP-induced pore formation and cell death. Immunostaining
of the SC culture with an anti-P2X7R antibody showed that
P2X7R immunoreactivity was absent in those fibroblasts
(unpublished observation).
Figure 3 ATP induces ethidium uptake by SCs. (a) Photomicrographs showing the morphological changes of SCs (phase contrast images) and ethidium fluorescence in
SCs 20 min after exposure to various concentrations of ATP. Green arrows in the two photomicrographs for 3 mM ATP point to two fibroblasts. (b) Quantification of ethidium
fluorescence intensities in SCs 20 min after exposure to various concentrations of ATP with or without oxATP (350mM) or A438079 (100mM) treatment. þþþPo0.001
(compared with the group without ATP); ***Po0.001 (compared between the corresponding groups with and without one of the antagonists), single factor AVNOA, n¼ 3.
(c) Representative time course of ethidium uptake by SCs after exposure to different concentrations of ATP over 20 min
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P2X7R antagonists inhibit ATP- and BzATP-induced
increase in free intracellular Ca2þ in SCs. ATP and other
P2 purinoceptor agonists have been reported to evoke the
increase of free intracellular Ca2þ ([Ca2þ ]i) in dissociated or
myelinating SCs.26,27 We tested a wider range of ATP
concentrations for a longer time (15 min) on SCs with and
without pretreatment with oxATP. From 1 to 300 mM ATP
evoked a rapid [Ca2þ ]i increase and the transient rise
gradually declined to and maintained at the baseline level
(Figure 4b). However, at 1, 3 and 5 mM ATP, after the peak
phase [Ca2þ ]i level gradually elevated again over the
recording period. Quantification of the intensity and duration
of the peak [Ca2þ ]i rise by combining the Fluo-4
fluorescence intensities during the first 100 s after ATP
application shows that the [Ca2þ ]i increase is generally
concentration-dependent (Figure 4d). However, the peak
phase of [Ca2þ ]i rise at 5 mM ATP was lower than those at
1 and 3 mM, a phenomenon that we are unable to explain
at the moment. Pretreatment with oxATP did not affect the
peak phase of [Ca2þ ]i rise evoked by ATP concentrations
lower than 300 mM but reduced the peak phases for 1 and
3 mM ATP (Figures 4c and d). Another obvious difference
between the two groups is that oxATP pretreatment
prevented the gradual [Ca2þ ]i rise after the peak response
at 1, 3 and 5 mM ATP (Figure 4c). Therefore, it is
postulated that the gradual [Ca2þ ]i rise after the peak
Figure 4 ATP increases [Ca2þ ]i level in SCs. (a) Sequential images of Fluo-4 fluorescence captured by a time-lapse microscope over a period of 44 s in SCs pretreated
with 350mM oxATP and then exposed to 30 mM ATP. (b) Representative time course of [Ca2þ ]i levels indicated by Fluo-4 fluorescence intensities in SCs after exposure to
different concentrations of ATP. (c) Representative time course of [Ca2þ ]i levels in SCs pretreated with oxATP (350mM) and then exposed to different concentrations of ATP.
(d) Quantification of Fluo-4 fluorescence intensities in SCs in the first 100 s (peak phase) after exposure to different concentrations of ATP with or without oxATP treatment.
*Po0.05, **Po0.01 (compared between groups exposed to the same concentration of ATP with and without oxATP), single factor ANOVA, n¼ 3
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may be due to the Ca2þ influx through the pores formed on
the membrane.
BzATP was also able to evoke [Ca2þ ]i rise in SCs
(Figure 5a), and quantification of the intensity and duration
of the peak phase of [Ca2þ ]i rise in the first 180 s after BzATP
application shows that the [Ca2þ ]i increase is generally
concentration-dependent (Figures 5a and c). BzATP at
30 mM evoked a small [Ca2þ ]i rise, whereas 100mM evoked
a much bigger [Ca2þ ]i rise that lasted longer than minimolar
ATP-evoked [Ca2þ ]i rise. After the peak response, [Ca
2þ ]i
remained at the baseline level. Three hundred micromolar
BzATP evoked a slightly bigger peak [Ca2þ ]i rise than
100mM; however, [Ca2þ ]i gradually elevated after the peak,
similar to that seen with minimolar ATP concentrations.
A438079 at 100mM significantly reduced BzATP-induced
peak [Ca2þ ]i rise and abolished the gradual [Ca
2þ ]i rise
induced by 300 mM BzATP (Figures 5b and c), indicating that
the [Ca2þ ]i rise induced by BzATP is mainly mediated by
P2X7R.
Pretreatment of SCs with oxATP improves their survival
after transplantation. To test whether blockade of P2X7R
can improve the survival of transplanted SCs, we exploited
the property of irreversible blockade of P2X7R by oxATP.
After the irreversible blockade of P2X7R, new P2X7Rs need
to be synthesized and transported to the cell membrane
before they become susceptible to ATP-induced death again.
First, we studied the time window for SCs to remain resistant
to ATP-induced cell death after oxATP treatment. SCs were
incubated with 350 mM oxATP for 2 h and oxATP was then
removed. At 2–6 h after oxATP removal, SCs were exposed
to 5 mM ATP. It was found that ATP-induced withdrawal of
cellular processes started to appear at 4 h after oxATP
removal and became more obvious at 6 h (data not shown).
This 4 h window may be long enough to offer a certain
degree of protection against ATP-induced SC death
after transplantation, as ATP release occurs instantly
at the site of transplantation and may last for several
hours.28
Figure 5 A438079 inhibits BzATP-induced [Ca2þ ]i increase in SCs. (a) Representative time course of [Ca
2þ ]i levels indicated by Fluo-4 fluorescence intensities in SCs
after exposure to different concentrations of BzATP. (b) Representative time course of [Ca2þ ]i levels in SCs exposed to different concentrations of BzATP with A438079
(100mM). (c) Quantification of Fluo-4 fluorescence intensities in SCs in the first 180 s (peak phase) after exposure to different concentrations of BzATP with or without
A438079. ***Po0.001 (compared between groups exposed to the same concentration of BzATP with and without A438079), single factor ANOVA, n¼ 3
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Five days before transplantation, SCs were transduced with
a GFP-expressing lentivirus for easy identification and
quantification. One dish of cells was treated with 350 mM
oxATP for 2 h, whereas another dish of untreated cells was
used as control. Both groups of cells were harvested
simultaneously and 100 000 cells were transplanted into
either side of dorsal columns at the thoracic eight level of
the spinal cord of adult rats (n¼ 4, Figure 6a). One week later,
animals were killed and the areas occupied by GFPþ SCs in
the spinal cord sections were measured using ImageJ
(NIH, Bethesda, MD, USA). Transplanted SCs mainly
remained at the injection site, with some cells spreading into
the host tissue (Figure 6b). Quantification data show that
34.9±7.2% more oxATP-treated SCs survived than the
untreated SCs after transplantation (Figure 6c, Po0.01,
paired Student’s t-test), indicating that blocking P2X7R in
SCs can improve their survival after transplantation.
P2X7R knockout enhances the survival of transplanted
SCs. To test whether SCs deficient of P2X7R can survive
better after transplantation, we isolated SCs from C57Bl/6J
wild-type and P2X7R-knockout mice, and then transduced
them with GFP-expressing adenovirus, as mouse SCs are
not susceptible to lentiviral transduction. The same numbers
of cells (100 000) from wild-type or P2X7R-knockout mice
were transplanted into either side of dorsal columns at the
thoracic eight level of the spinal cord of adult rats (n¼ 5).
Animals were injected with ciclosporin daily after surgery to
suppress immune rejections. One week later, animals were
killed and the areas occupied by GFPþ SCs in the spinal
cord sections (Figure 7b) were measured using ImageJ.
It was found that 54.8±8.8% more SCs from P2X7R-knockout
mice survived compared with those from wild-type
mice (Figure 7c, Po0.01, paired Student’s t-test), which
indicates that P2X7R knockout can promote the survival of
transplanted SCs.
Discussion
An important discovery in the current study is that high
concentrations of ATP can induce SC death in vitro.
The evidence provided indicates that the P2X7R is the
Figure 6 Blockade of P2X7R on SCs increases their survival after transplantation. (a) Diagram illustrating the transplantation of GFP-expressing SCs (GFP/SCs) with or
without oxATP treatment into either side of the dorsal column of rat T8 spinal cord. (b) Photomicrographs showing GFP/SCs transplanted into the spinal cord. Dashed line
indicates midline of spinal cord. (c) Quantification of the areas occupied by GFP/SCs with or without oxATP pretreatment in the spinal cords of four rats (data from the same
animal are linked by colored lines)
Figure 7 P2X7R-deficient SCs are resistant to ATP-induced cell death and survive better after transplantation. (a) Flow cytometry apoptosis assay showing that 5 mM
ATP induced significant death of SCs from wild-type (WT) mice, whereas SCs from P2X7R-knockout (KO) mice did not show obvious cell death. ***Po0.001, Student’s
t-test, n¼ 4. (b) Photomicrograph showing the surviving GFP-expressing mouse SCs from WT or P2X7R KO mouse 1 week after transplantation into rat spinal cords.
(c) Quantification of the areas occupied by GFP/SCs from WT or P2X7R KO mice transplanted into the spinal cords of five rats (data from the same animal are linked
by colored lines)
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purinoceptor subtype that mediates SC death. The first line of
evidence is that only high concentrations of ATP can induce
significant SC death. It is well-known that prolonged activation
of P2X7R by ATP in minimolar concentrations leads to the
formation of large transmembrane pores resulting in the
movement of solutes across membranes and cell death. ATP-
induced SC death is concentration-dependent; however, cell
death occurs in a rather narrow range of concentrations,
which has also been observed in ATP-induced death of
dendritic cells and neural progenitor cells.15,21 The steep
concentration-response curve may be due to that the extent of
pore formation reaches a critical level at a certain concentration
of ATP and the leakage of intracellular contents becomes so
severe in some cells that they enter the death path
irreversibly. This is supported by our observation that ethidium
uptake became evident at 2 mM ATP, so did the morpho-
logical changes of SCs; however, no significant cell death was
detected using flow cytometry at this concentration. Cell death
becomes statistically significant at 3 mM ATP.
The significant SC death induced by BzATP may provide
another line of evidence to support that P2X7R is responsible
to SC death. However, it should be noted that BzATP may act
as a partial agonist for other P2X and P2Y receptor
subtypes.29 Both ATP- and BzATP-induced cell death was
completely blocked by P2X7R antagonists oxATP and
A438079. These two antagonists also completely blocked
the ethidium uptake induced by minimolar ATP concentra-
tions, further supporting that pore formation on SC membrane
may lead to cell death.
ATP at concentrations from 1 to 5 mM can evoke [Ca2þ ]i
increase in SCs. oxATP only significantly reduced the peak
[Ca2þ ]i increase induced by 1 and 3 mM ATP, whereas it had
no significant effect on lower concentration of ATP. oxATP
also abolished the gradual [Ca2þ ]i rise after the peak
response that was only obvious at minimolar ATP
concentrations. The results further implicate that oxATP
can efficiently block the P2X7R in SCs.
The last, also the most convincing, evidence to support that
P2X7R is responsible for ATP-induced SC death is from the
cell viability assay of SCs from P2X7R-knockout mice, which
shows that disruption of P2X7R gene expression abolished
the ATP-induced SC death. All the evidence above indicates
that P2X7R is the receptor subtype that is responsible for
ATP-induced cell death.
We speculate that ATP may contribute to the death of the
transplanted SCs in the spinal cord. One crucial question is
whether ATP released during the transplantation procedure
will reach concentrations high enough to induce SC death. It is
known that ATP concentrations in cells are in the range of
1–10 mM.30 Upon cell breakage after injury, intracellular ATP
will be released and the local concentration of ATP could reach
the minimolar level. Sustained high-level ATP release at the
site of a spinal cord injury was reported to last for 6 h.28 In cell
transplantation procedures, even when carried out very
carefully to minimize damage to the host tissue, a certain
degree of injury is inevitable. Furthermore, ATP released by
injury will attract microglia and macrophages to the trans-
plantation site and these cells may release more ATP.8 We did
observe the accumulation of Iba-1 (a microglia and macro-
phage marker) positive cells around the SC implants 1 day
after transplantations (data not presented). Therefore, it is
highly possible that ATP released at the transplantation site
may reach the minimolar level and induce the death of
transplanted SCs.
By using the irreversible antagonist oxATP to block P2X7R
on SCs before transplantation, we were able to significantly
increase the survival of SCs in the spinal cord. Furthermore,
P2X7R knockout in SCs showed an even larger increase in
SC survival after transplantation. Taken together, these data
indicate that ATP and P2X7R are involved in the cell death
after transplantation. However, to improve the survival of
transplanted SCs by pretreatment with oxATP may not be an
ideal approach, as oxATP has other targets such as ATP-
binding enzymes31 and may be cytotoxic.32 At 350mM, oxATP
itself does not affect SC viability. Another reason is that,
although the blockade by oxATP is irreversible, newly
synthesized P2X7R will make SCs sensitive to ATP again
4 h after oxATP removal. This may partially explain why more
P2X7R knockout SCs survived than oxATP-treated SCs
in vivo. However, it should be noted that mouse SCs were
more susceptible to ATP-induced cell death in vitro, which
may be attributed to species difference. Other approaches
that specifically target P2X7R and have longer lasting effects
need to be developed. One potential approach is to use small
interfering RNA (siRNA) to knockdown P2X7R in SCs before
transplantation.
P2X7R has been reported to participate in the processing
and release of cytokines, such as interleukin-1b (IL-1b), and in
the initiation of cell death via both apoptotic and necrotic
pathways.33 In the CNS, P2X7R has been implicated in many
pathological processes, including neuroinflammation.16,34,35
P2X7R-mediated release of inflammatory factors at the injury
site may also contribute to the death of transplanted cells. In
the normal rodent brain, P2X7R expression in astrocytes is
generally quite low, but quickly upregulated in response
to brain injury or pro-inflammatory stimulation in cell
culture conditions.36,37 In astrocytes, P2X7R activation can
potentiate pro-inflammatory signaling, as it enhances IL-1b-
induced activation of nuclear factor-kB and activator
protein 1.38,39 Such processes may lead to more inflammatory
factor release via the activation of P2X7R. It is likely that more
cell death will occur after cells are transplanted into the
lesioned spinal cord. It was reported that intravenous
administration of Brilliant Blue G (BBG), a selective P2X7R
antagonist, significantly reduced spinal cord damage.40 BBG
treatment also directly reduced local activation of astrocytes
and microglia and neutrophil infiltration. We predict that
administration of a P2X7R antagonist to rats before trans-
plantation may also enhance the survival of transplanted SCs.
If such treatment is effective, further enhancement of SC
survival may be achieved by combining the administration of
P2X7R antagonist with P2X7R knockdown in SCs.
In conclusion, the results from the present study indicate
that blocking P2X7R on SCs promotes their survival after
transplantation, which may lead to improved neural repair.
As many other types of cells, such as neural stem cells
and pancreatic beta cells, also express P2X7R, our
finding that P2X7R is involved in the death of transplanted
cells may have a significant impact in the cell therapy
field.
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Materials and Methods
SC culture and viral vector transduction. SCs were isolated from the
sciatic nerves and brachial plexus of Wistar rats or C57Bl/6J mice of postnatal day
2 as described previously.41,42 Cells were then maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), 25 ng/ml
b-heregulin (R&D Systems Europe Ltd, Abingdon, UK), 2 mM forskolin
(Sigma-Aldrich, Poole, UK), 25 ng/ml fibroblast growth factor (PeproTech EC
Ltd, London, UK) and 5 mg/ml insulin (Sigma-Aldrich). The purity of all primary SC
cultures was evaluated by immunostaining for the SC markers p75 neurotrophin
receptor (p75NTR) and S100. Highly purified cultures (495% SCs), up to three
passages, were used in all experiments. For easy identification after
transplantation, cultured rat SCs were transduced with a GFP-expressing third
generation lentiviral vector made in our lab42,43 at a MOI of 10 and the
transduction efficiency was about 95%. Mouse SCs were transduced with
GFP-expressing adenoviral vector made in our lab at a MOI of 10 and the
transduction efficiency was about 98%.
The P2X7R KO mice (homozygotes) were gifts from GlaxoSmithKline (Harlow,
UK). Mice carrying a targeted null mutation of the P2X7 gene were generated by
inserting LacZ gene into Exon 1 of P2X7 gene to disrupt the P2X7 gene.44 Germline
chimaeras were crossed with C57Bl/6J females to generate heterozygotes, and a
further six backcrosses onto the C57Bl/6J strain were performed before producing
homozygotes for study.
Immunohistochemistry. Rat SCs and 10mm thick cryostat sections of the
sciatic nerves from rat, wild-type and P2X7R KO mice were fixed with 4%
paraformaldehyde and blocked in 10% normal donkey serum in PBS. The cells or
tissue sections were incubated with a polyclonal antibody for P2X7R (1 : 70,
Alomone, Jerusalem, Israel) and a monoclonal antibody for S100 (1 : 2000,
Sigma-Aldrich). Primary antibodies were diluted in 10% normal donkey
serum containing 0.2% Triton X-100 plus 1% bovine serum albumin in PBS.
Secondary antibodies applied were donkey anti-mouse IgG-FITC (1 : 400, Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, USA) and donkey anti-rabbit
IgG-TRITC (1 : 400, Jackson ImmunoResearch Laboratories Inc.).
PCR. Cellular RNAs were extracted from SCs using TRIzol Reagent (Invitrogen,
Life Technologies, Paisley, UK) and reverse transcribed using random
hexanucleotide primers and SuperScript III Reverse Transcriptase (Invitrogen).
cDNAs obtained were used for amplifying P2X7R cDNA with 30 PCR cycles.
Aliquots of PCR products were electrophoresed in a 2% agarose gel. A plasmid
containing P2X7R cDNA was used as a positive control.
Cell viability assays. SCs were cultured in 35 mm dishes to 65–70%
confluence when experiments were performed. ATP solutions were prepared in
PBS and adjusted to pH 7.2. After exposure to various concentrations of ATP
and/or other compounds, cells were dissociated after trypsin treatment. Trypsinized
SCs were centrifuged at 180 g for 10 min and cell viability was measured using
an Annexin Apoptosis Assay kit (BD Biosciences, Oxford, UK). SCs were
resuspended in 400ml Annexin V binding buffer and incubated with 2 ml Annexin
V-FITC at room temperature for 15 min, then 5mg/ml (final concentration) viability
dye propidium iodide was added. The samples were subjected to flow cytometry.
Ethidium uptake. SCs were cultured in 24-well plates (Nunc). Ethidium
uptake was monitored by stimulating SCs in culture medium with various
concentrations of ATP in the presence of 10 mM ethidium bromide for 20 min.
Using an inverted fluorescence microscope (Nikon Eclipse TE-2000E) cells were
photographed with a 670 nm filter from three randomly chosen fields of view with
fixed exposure time for all micrographs. For quantification of ethidium uptake,
integrated densities of ethidium fluorescence in 20 randomly chosen cells from
each micrograph were measured using ImageJ. The experiments were repeated
using three different batches of cells.
To determine the time course of ethidium uptake after exposure of ATP, SCs in
24-well plates were placed on the stage of a spinning disk confocal microscope
(Andor Technology plc, Belfast, UK) fitted with an environmental chamber
(maintained at 37 1C). Ethidium bromide was added to the well to a final
concentration of 10mM. Cells were visualized using a Nikon  10 objective
(0.3NA). Ethidium was excited at 561 nm laser and emitted fluorescence was filtered
with a 580–620 nm bandpass filter. Images were captured on an iXon 885 EM CCD
camera using IQ software (Andor Technology plc) over a period of 20 min at 20 s
intervals. Two images were captured before the application of ATP to establish the
baseline of ethidium fluorescence. ImageJ was used to quantify the ethidium uptake
after exposure to ATP, and integrated densities of ethidium fluorescence in 10
randomly chosen cells in each captured image were measured and averaged. The
experiments were repeated three times using different batches of cells.
Calcium imaging. SCs were cultured in 24-well plates and loaded with Fluo-4
Direct (Invitrogen) for 20 min at 37 1C. Cells were visualized with the same
confocal microscope described above. The Fluo-4 was excited using a 488 nm
laser and emitted fluorescence was filtered with a 505–530 nm bandpass filter.
Time-lapse images were captured over a period of 15 min at 4 s intervals. Five
images were captured as baseline before ATP or BzATP was applied to the well.
To quantify the changes of [Ca2þ ]i, integrated densities of fluorescence intensities
in 10 randomly chosen cells in each captured image were measured and averaged
using ImageJ. The integrated densities of fluorescence from the same cells before
the application of ATP were subtracted from all the measurements after the
application of ATP. The experiments were repeated three times using different
batches of SCs.
Cell transplantation. All animal work was performed in accordance with the
Animals (Scientific Procedures) Act 1986 of the UK and covered by project and
personal licenses issued by the Home Office. The protocol was approved by the
Animal Ethical Review Committee of Queen Mary University of London. All efforts
were made to minimize animal use and suffering. Adult female Wistar rats
(200–250 g) were anesthetized with isoflurane, and GFP-expressing SCs (100 000 in
1 ml DMEM) were injected into either side of the dorsal column at the eighth
thoracic segment of the spinal cord with a 33 gauge metal needle at a speed of
200 nl/min.42 For rats receiving mouse SC transplants, ciclosporin was injected
intraperitoneally (10 mg/kg, daily) till the animals were killed. As cell death mainly
occurs in the first week after transplantation, the rats in the study were maintained
for 1 week before killing. Rats were perfused with 4% paraformaldehyde and the
spinal cord segments containing the transplants were removed and sectioned at
15mm thickness with a cryostat.
To quantify the cell survival in vivo, the areas occupied by transplanted rat or
mouse SCs (visualized by GFP fluorescence) were measured in consecutive
parasagittal sections of spinal cord (45 mm apart) with ImageJ. Statistical
significance was determined using paired Student’s t-test.
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